Can a nasal spray help autism symptoms? new study investigates

NCT ID NCT07521371

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study follows about 12 children and young adults (ages 4 to 21) with autism who are already using intranasal insulin as part of their regular care. Researchers want to see if this treatment is safe and if it helps with social skills, communication, and behavior over 6 months. No new treatment is given—the study just observes what happens in real life.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AUTISM SPECTRUM DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Healing Hope International

    Spring, Texas, 77386, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.